TaƱahura, Crisjan Q.
HRN: 21-15-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
CEFTRIAXONE 1G (VIAL)
08/25/2022
09/01/2022
IV
680
OD
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes